Search

everythinglearnresearchcommunity

for

Search:↓

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

DNCB is highly effective for treating alopecia areata with minimal long-term side effects.

DMBT1 and galectin-3 may help suppress epithelial skin cancer.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

DA-9401 helps protect rat testis from finasteride damage.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Two new compounds were found to effectively reduce hair growth in mice.

Hyaluronic acid reduces cell damage from DMSO in preserved human cells.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Dissolving microneedles offer efficient, minimally invasive drug delivery through the skin.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

New compounds may help treat prostate cancer by reducing cell growth.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

DK peptides can reduce hair loss by inhibiting the 5α-reductase enzyme and have antioxidant effects.

MK-386 lowers DHT in blood and skin but not in semen.

Modifying steroidal inhibitors shows promise for developing new cancer treatments.

Lower dosages of 2-(difluoromethyl)-dl-ornithine might reduce side effects, supporting further research.

A new compound effectively inhibits human 5α-reductase 1.